All Stories

  1. Same Target, Different Tools: A Multicenter Comparison of Clinically Significant Prostate Cancer Detection Across Three MRI-Targeted Transperineal Biopsy Techniques
  2. Reply by Authors
  3. Performance of 99m Tc-Sestamibi Single-Photon Emission Computed Tomography/Computed Tomography for Characterizing Renal Masses: Combined Results From a Prospective Scan-and-Resect Trial and Clinical Ex...
  4. Reply by Authors
  5. Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function
  6. Association of Socioeconomic Position, Prostate-specific Antigen, and Age with Observation in Low-risk Prostate Cancer Patients in Switzerland
  7. Comparison of Retzius-sparing versus anterior robotic-assisted radical prostatectomy in patients with prior transurethral resection of the prostate (TURP)
  8. High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?
  9. Anxiety and Health-related Quality of Life in Men with Prostate Cancer Undergoing Focal Therapy: A Prospective Single-arm Phase 2 Trial
  10. Diagnostic Value of Micro‐Ultrasound in Identifying Local Recurrence After Radical Prostatectomy
  11. Long-term follow-up after initial negative prostate biopsy—comparison of conventional transrectal ultrasound biopsy and mpMRI/transrectal ultrasound fusion guided biopsy
  12. Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT–based nomogram
  13. Issue Information
  14. PD04-09 MACHINE LEARNING-BASED PREDICTIVE MODEL OF CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) AND A RISK CALCULATOR: A MULTI-INSTITUTIONAL STUDY WITH INTERNAL AND EXTERNAL VALIDATION
  15. V03-05 MICRO-ULTRASOUND GUIDED PROSTATIC BED BIOPSY FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE POST RADICAL PROSTATECTOMY
  16. Case of the Month from the Icahn School of Medicine at Mount Sinai, New York, NY: MRI / TRUS fusion‐guided biopsy of a local prostate cancer recurrenc...
  17. A Novel Machine Learning-based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator
  18. Lack of effect of renal function on uptake of 99mTc-sestamibi in renal masses
  19. Undetectable pre-surgery tumor DNA predicts better outcomes in bladder cancer patients
  20. Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy
  21. Pilot Study: 99mTc-tetrofosmin for Characterizing Indeterminate Renal Masses
  22. Imaging of Chromophobe Renal Cell Carcinoma with 99mTc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification
  23. Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays
  24. PD02-07 POSITIVE CTDNA STATUS BEFORE RADICAL CYSTECTOMY PREDICTS LYMPH NODE STATUS AND PATHOLOGICAL UPSTAGING
  25. MP56-11 SINGLE PORT ADVANCED RESEARCH CONSORTIUM (SPARC). SINGLE PORT ACCESS COMPARISON FOR RETRO-PERITONEAL ROBOTIC PARTIAL NEPHRECTOMY: INDIVIDUALIZING SURGICAL APPROACH
  26. PD38-01 NEGATIVE CTDNA STATUS PRIOR TO RADICAL CYSTECTOMY PREDICTS IMPROVED OUTCOMES
  27. BioPrev-C – development and validation of a contemporary prostate cancer risk calculator
  28. Funktionelle Ergebnisse nach fokaler Therapie bei lokal begrenztem Prostatakarzinom
  29. Résultats fonctionnels après un traitement focal pour un cancer de la prostate localisé
  30. Validation of a Zero-shot Learning Natural Language Processing Tool to Facilitate Data Abstraction for Urologic Research
  31. Functional Outcomes of Prostate Cancer Treatment with Partial Gland Ablation
  32. SAFE Technique for Improved Outcomes in Robot-Assisted Prostatectomy
  33. Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-analysis of Prospective Studies
  34. Intraoperative Fluorescent Image Guidance for Nerve-Sparing Prostatectomy: A Review of Historical Context and Current Research
  35. Focal HIFU for Prostate Cancer: 3-Year Outcomes and Functional Outcomes
  36. Atherosclerosis of the iliac arteries for the prediction of erectile dysfunction and epistaxis in men undergoing abdominal CT scan
  37. Microultrasound in the detection of the index lesion in prostate cancer
  38. Proclarix: A Promising Tool for Prostate Cancer Detection
  39. Retrospective analysis of the uptake of active surveillance for low-risk prostate cancer in Zurich, Switzerland
  40. Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer
  41. Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
  42. Tumor Stent for Chronic Ureteral Obstruction: Which Are Predictors of Stent Failure?
  43. PD11-02 EVALUATION OF VARIETY AND PERFORMANCE BETWEEN PSA ASSAYS AND PHI IN A CLINICAL COHORT OF MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER
  44. Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
  45. Diagnostic accuracy of PSMA-PET-CT for pelvic lymph node staging in men with prostate cancer undergoing radical prostatectomy and pelvic lymph node dissection
  46. The Biopsy Prevention Calculator (BioPrev C): A novel prediction tool to avoid unnecessary prostate biopsies
  47. Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer
  48. Long-term prognostic performance of low-dose coronary computed tomography angiography with prospective electrocardiogram triggering
  49. MP38-10 COMPLICATIONS FOLLOWING EXTENDED TRANSPERINEAL TEMPLATE MAPPING MRI/TRUS FUSION BIOPSY OF THE PROSTATE – INITIAL EXPERIENCE FROM 421 PROCEDURES
  50. Complications following extended transperineal template mapping MRI/TRUS fusion biopsy of the prostate – initial experience from 421 procedures